Herpes Labialis
33
1
1
26
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Published Results
13 trials with published results (39%)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
12.1%
4 terminated out of 33 trials
86.7%
+0.2% vs benchmark
27%
9 trials in Phase 3/4
50%
13 of 26 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 26 completed trials
Clinical Trials (33)
Viral Infections in Healthy and Immunocompromised Hosts
Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 1 Infection
Immune Response and General Immune Health in Subjects Infected With Herpes Simplex Virus Type 1 (HSV-1)
Double-blind, Vehicle-controlled Study of the Efficacy and Safety of SADBE in Subjects With Recurrent Herpes Labialis
Comparative Safety and Efficacy of Two Antiviral Treatments in the Treatment of Recurrent Herpes Simplex Labialis
A Phase 2, Muti-Center Study of Repeat Dosing of Squaric Acid Dibutyl Ester in Subjects With Herpes Labialis
Trial on Efficacy and Safety of Pritelivir Ointment for Treatment of Labial Herpes
Safety and Pharmacokinetics of Famciclovir Single 1500 mg Dose in Adolescents With Recurrent Herpes Labialis
Botulinum Toxin A for Herpes Labialis
Safety, Tolerability and Therapeutic Efficacy of Topical ZEP-3 Ointment (1.0%) for the Treatment of Cold Sores
Bioequivalence Study of Aciclovir 5% Cream in Japanese Healthy Volunteers
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2
Immune Evidence to the Consumption of Lactobacillus GG and FOS Consumption in Patients With Herpes Labialis
Immune Response to the Consumption of Lactobacillus GG and FOS in Patients With Recurrent Herpes Labialis
Safety and Efficacy of Squaric Acid Dibutyl Ester for the Treatment of Herpes Labialis
Study of a New Topical Natural Health Product for the Treatment of Herpes Labialis
A Double-Blind, Randomized, Placebo-Controlled Study of Topical VDO for the Treatment of Herpes Simplex Labialis
An Exploratory Study to Investigate the Inflammatory Response During a Cold Sore Episode
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
NB-001 Treatment of Recurrent Herpes Labialis